HomeCompareETR vs SYK

ETR vs SYK: Dividend Comparison 2026

ETR yields 2.23% · SYK yields 1.04%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SYK wins by $4.2K in total portfolio value· pulled ahead in Year 9
10 years
ETR
ETR
● Live price
2.23%
Share price
$111.06
Annual div
$2.48
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.1K
Annual income
$4,951.65
Full ETR calculator →
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →

Portfolio growth — ETR vs SYK

📍 SYK pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodETRSYK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ETR + SYK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ETR pays
SYK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ETR
Annual income on $10K today (after 15% tax)
$189.81/yr
After 10yr DRIP, annual income (after tax)
$4,208.90/yr
SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
At 15% tax rate, SYK beats the other by $2,831.63/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ETR + SYK for your $10,000?

ETR: 50%SYK: 50%
100% SYK50/50100% ETR
Portfolio after 10yr
$41.2K
Annual income
$6,617.32/yr
Blended yield
16.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

ETR
Analyst Ratings
18
Buy
13
Hold
Consensus: Buy
Price Target
$104.67
-5.8% upside vs current
Range: $96.00 — $112.00
Altman Z
1.1
Piotroski
5/9
SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ETR buys
0
SYK buys
0
No recent congressional trades found for ETR or SYK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricETRSYK
Forward yield2.23%1.04%
Annual dividend / share$2.48$3.40
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR29%46.2%
Portfolio after 10y$39.1K$43.3K
Annual income after 10y$4,951.65$8,282.98
Total dividends collected$16.6K$21.0K
Payment frequencyquarterlyquarterly
SectorUtilitiesHealthcare
Analyst consensusBuyBuy
Analyst price target$104.67$428.67

Year-by-year: ETR vs SYK ($10,000, DRIP)

YearETR PortfolioETR Income/yrSYK PortfolioSYK Income/yrGap
1$10,988$288.06$10,852$152.43+$136.00ETR
2$12,139$381.60$11,838$226.03+$301.00ETR
3$13,497$508.24$13,004$336.89+$493.00ETR
4$15,123$681.29$14,420$505.63+$703.00ETR
5$17,102$920.32$16,195$766.09+$907.00ETR
6$19,554$1,254.74$18,504$1,175.64+$1.1KETR
7$22,652$1,729.61$21,635$1,835.40+$1.0KETR
8$26,653$2,415.64$26,082$2,932.10+$571.00ETR
9← crossover$31,946$3,426.75$32,737$4,829.68$791.00SYK
10$39,134$4,951.65$43,312$8,282.98$4.2KSYK

ETR vs SYK: Complete Analysis 2026

ETRUtilities

Entergy Corporation, together with its subsidiaries, engages in the production and retail distribution of electricity in the United States. The company operates in two segments, Utility and Entergy Wholesale Commodities. The Utility segment generates, transmits, distributes, and sells electric power in portions of Arkansas, Louisiana, Mississippi, and Texas, including the City of New Orleans; and distributes natural gas. The Entergy Wholesale Commodities segment engages in the ownership, operation, and decommissioning of nuclear power plants; and ownership of interests in non-nuclear power plants that sell electric power to wholesale customers, as well as provides services to other nuclear power plant owners. It generates electricity through gas, nuclear, coal, hydro, and solar power sources. The company sells energy to retail power providers, utilities, electric power co-operatives, power trading organizations, and other power generation companies. The company's power plants have approximately 26,000 megawatts (MW) of electric generating capacity, which include 6,000 MW of nuclear power. It delivers electricity to 3 million utility customers in Arkansas, Louisiana, Mississippi, and Texas. The company was founded in 1913 and is headquartered in New Orleans, Louisiana.

Full ETR Calculator →

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →
📬

Get this ETR vs SYK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ETR vs SCHDETR vs JEPIETR vs OETR vs KOETR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.